Trial Outcomes & Findings for Smoking Cessation in Alcoholics (NCT NCT00963482)

NCT ID: NCT00963482

Last Updated: 2015-03-27

Results Overview

Smoke-free defined with following measures: * patients self-report about smoking in the last 7 days (yes/no) * CO-level (smoke-free \<10ppm) * urine sample (cotinine)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

103 participants

Primary outcome timeframe

6 months

Results posted on

2015-03-27

Participant Flow

01.07.2007-31.01.2010 Recruiting process 31.01.2010-31.07.2011 last follow-up sessions location of recruiting: alcohol detoxification unit follow-up: outpatient

Out of 237 screened patients, 103 were enrolled. Intervention group(EG)=53; Control group (CG)=50.

Participant milestones

Participant milestones
Measure
Intervention Group
Cognitive-behavioural smoking cessation program
Control Group
Autogenic training
Overall Study
STARTED
53
50
Overall Study
COMPLETED
25
33
Overall Study
NOT COMPLETED
28
17

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Smoking Cessation in Alcoholics

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention Group
n=53 Participants
Cognitive-behavioural smoking cessation program
Control Group
n=50 Participants
Autogenic training
Total
n=103 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
53 Participants
n=5 Participants
50 Participants
n=7 Participants
103 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
44 years
STANDARD_DEVIATION 11 • n=5 Participants
44 years
STANDARD_DEVIATION 9 • n=7 Participants
44 years
STANDARD_DEVIATION 10 • n=5 Participants
Sex: Female, Male
Female
16 Participants
n=5 Participants
14 Participants
n=7 Participants
30 Participants
n=5 Participants
Sex: Female, Male
Male
37 Participants
n=5 Participants
36 Participants
n=7 Participants
73 Participants
n=5 Participants
Region of Enrollment
Switzerland
53 participants
n=5 Participants
50 participants
n=7 Participants
103 participants
n=5 Participants

PRIMARY outcome

Timeframe: 6 months

Population: Intention-to-treat analysis

Smoke-free defined with following measures: * patients self-report about smoking in the last 7 days (yes/no) * CO-level (smoke-free \<10ppm) * urine sample (cotinine)

Outcome measures

Outcome measures
Measure
Intervention Group
n=46 Participants
Cognitive-behavioural smoking cessation program
Control Group
n=43 Participants
Autogenic training
Number of Smoke-free Patients
0 participants
3 participants

SECONDARY outcome

Timeframe: 6 months

Outcome measures

Outcome data not reported

Adverse Events

Intervention Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

M. Sc. S. Müller (Site-investigator) Prof. G. A. Wiesbeck (PI)

Divsion Substance Use Disorder, Psychiatric Hospital of the Univeristy of Basel

Phone: +41 61 325 53 33

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place